Martina Porter is a Dermatology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 134 publications with 1,160 citations (h-index 18); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
Boston, MA 022155491
Telephone
617-667-4995Provider last certified this registry record 18 Nov 2025.
Clinical trials
- The Safety and Efficacy of Roflumilast Foam in HS
Sponsor: Beth Israel Deaconess Medical Center
- Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
Sponsor: Beth Israel Deaconess Medical Center
- Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
Sponsor: Beth Israel Deaconess Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202518 payments$31,130openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year202521 payments$15,353openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20254 payments$12,639openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hidradenitis Suppurativa: New Targets and Emerging Treatments
American Journal of Clinical Dermatology
2024 - Biologics in hidradenitis suppurativa: Progress and new directions
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”